Summary: RNA-RNA in situ hybridization is a reliable method for studying tissue and cell specific gene expression, which enables visualization of labeled antisense RNA probe hybridized to specific mRNA. In this study we employed non-radioactive RNA-RNA in situ hybridization using biotin-or digoxigenin-labeled RNA probes in order to detect SOX gene expression in carcinoma cell lines. By this approach we confirmed results obtained by Northern blot analysis, where the presence of SOX2 mRNA in NT2/D1 and SOX14 mRNA in HepG2 cells has been established. Our aim was to set up RNA-RNA in situ hybridization method in in vitro cultured cells in order to perform further analyses of SOX gene expression on various normal and cancer tissues.
Introduction
The in situ hybridization techniques are a powerful tool for studying tissue and cell specific gene expression (1) . The use of this method for the detection of messenger RNA molecules is increasing in recent years, and it has a broad application in basic science and diagnostic clinical research (2) .
RNA-RNA in situ hybridization is based on the ability of RNA molecules to form stable hybrids. The non-radioactively labeled single-stranded probes of antisense RNA are generated by in vitro transcription and hybridized to cellular mRNA (1) . This type of hybrids is particularly stable and allows stringent washing conditions resulting in highly specific signal with low background (3) . Therefore, RNA-RNA in situ hybridization is preferable in detection of mRNA in cells compared to DNA-RNA in situ hybridization.
Non-radioactively labeled probes are widely used and non-radioactive in situ hybridization is a method of preference compared with the radioactive one. It is safe, probes can be stored for long periods without loss of activity, the hybridization sites can be detected quickly and by using different probe labels it is possible to detect several sequences simultaneously (4).
The SOX genes comprise a family of transcriptional regulators (5) . They function both as classical transcription factors and as modulators of chromatin structure (6) . Expression patterns and functional analyses suggest that Sox proteins are involved in control of nervous system development, lens development, chondrogenesis and sex determination (7).
Recently, there is an increasing evidence that Sox genes have oncogenic potential. For example, human SOX7 mRNA was significantly up regulated in pancreatic cancer cell lines, as well as in some cases of primary gastric cancer, and it was significantly down regulated in several cases of primary colorectal, breast, kidney, lung, and prostate cancer (8). Xia et al. (9) reported that overexpression of cSox3 from retroviral vector transfected in chicken embryo fibroblasts induced oncogenic transformation and aberrant cell growth. Furthermore, loss-of-function mutations of Xenopus Sox17a, Sox17b, Sox3, and mouse Sox7, which are all reported to be negative regulators of the WNT-b-catenin-TCF pathway, lead to carcinogenesis (10) . Also, it was reported that human SOX1 and SOX2 are immunogenic tumour antigens found in small cell lung cancer (11) , while human SOX10 encodes a melanoma/melanocyte differentiation antigen recognized by CTLs (12) .
The aim of this study was to analyze SOX gene expression by non-radioactive RNA-RNA in situ hybridization in human carcinoma cell lines. Precisely, we examined SOX2 and SOX14 mRNA in NT2/D1 human embryonal carcinoma cell line and in hepatocellular carcinoma cell line (HepG2), respectively. Our goal was to set up the method in cell lines in order to test human SOX gene expression in tumour and normal tissues, and explore the possibility if this family of genes was involved in tumourogenesis.
Materials and Methods

Plasmid DNA
DNA fragments, which served as templates for in vitro transcription in our study, were incorporated into transcription vector pBluescriptT II KS+ phagemid (Stratagene Cloning Systems, San Diego, CA). These inserts are: FbCl2 clone which contains complete ORF of human SOX2 gene (13) and P3PstI clone which contains 700bp SOX14 gene fragment, encompassing HMG-box (14) .
Both plasmids were purified by Wizard minipreps DNA purification system (PROMEGA).
Cell culture
The NT2/D1 cells (ATCC Number: CRL-1973) and HepG2 cells (ATCC Number: HB 8065) were maintained in DMEM (Gibco BRL), supplemented with 10% foetal bovine serum (Gibco BRL). 1× MEM Nonessential Amino Acid (SIGMA) was added to HepG2 growth medium. Cells were incubated at 37 °C in either a 10% CO 2 atmosphere (NT2/D1 cells) or 5% CO 2 atmosphere (HepG2 cells), allowed to grow near confluency and harvested by trypsin. Cells were then pelleted by centrifugation and resuspended in fresh growth medium. Viable cell counts were determined by trypan blue staining and 1×10 5 cells were seeded per 24×24 mm poly-L-lysine treated coverslips. Coverslips with the cells were then placed in a 60 mm tissue culture dishes, incubated for 1 hour at 37 °C in order to allow cell attachment and finally 3 mL of the growth medium was added to dishes. Cells were incubated overnight at 37 °C in appropriate CO 2 atmosphere.
In vitro transcription
FbCl2 was linearized with PstI restriction enzyme for both sense and antisense synthesis. P3PstI was linearized with EcoRI (antisense) and BamHI (sense). Linearized plazmids were then treated with 0.5% SDS and 100 mg/mL proteinase K at 50 °C for 30 minutes and were purified by phenol-chloroform extraction and ethanol precipitation.
The transcription was performed in 20 mL reaction containing 1 mg linearized plasmid (sense or antisense), 2.5 mmol/L each rATP, rCTP, rGTP, 1.5 mmol/L rUTP, 0.5 mmol/L biotin-16-uridin-5'-triphosphate or 0.5 mmol/L digoxigenin-11-uridine-5'-triphosphate, 1 ×Transcription Buffer, 10 mmol/L DTT, 40 U Recombinant RNasin Ribonuclease Inhibitor and 20 U of either T7 or T3 RNA polymerase. Control in vitro transcription reaction was performed with rNTPs, 2.5 mmol/L each. The reaction was incubated 2 hours at 37 °C and after that template DNA was removed by adding 2U RNase-free DNaseI.
The reaction was stopped by 1 mL 0.5 mol/L EDTA. G-50 spin columns and precipitation were used in order to remove free nucleotides from the reaction.
The quality of biotin-and digoxigenin (DIG)-labeled RNA probes was checked on 1 % agarose gel.
In situ hybridization
The probe mixture contained 50 ng probe, 6 mg of salmon sperm DNA, and 3 mg tRNA was dried down in a vacuum centrifuge, resuspended in 10 mL deionized formamide and then denatured by boiling for 10 min. Then, equal volume of hybridization buffer (4 ×SSC, 0.02 mol/L DTT and 20% dextran sulfate) was added to probe mixture.
The cells on coverslips were washed in phosphate buffered saline (PBS; pH 7.4), fixed in 4% paraphormaldehyde/PBS-MgCl 2 for 10 min at room temperature, followed by addition of cold 70% ethanol and placed at '20 °C until use. The cells were rehydrated in Tris-HCl/glycine and prehybridized in 50% deionized formamide/4×SSC at 65 °C for 10 min. After the prehybridization coverslips were inverted onto 20 mL droplets of probe on parafilm, covered with second sheet of parafilm and incubated over night in hybridization buffer at 42°°C.
Following hybridization, the coverslips were incubated at 37°°C on droplets of prewarmed RNase solution (40 mg/mL RNase A, 2 mg/mL RNase T1, 10 mmol/L Tris-HCl pH 7.5, 5 mmol/L EDTA, 0.3 mol/L NaCl) to remove unhybridized probe. Then, coverslips were washed with agitation at 37°°C in 2×SSC for 30 minutes, in 1×SSC for 15 minutes and in 0.5×SSC for 15 minutes.
Detection of biotin-labeled RNA probes. Detection was performed as described (15) . The biotinylated probes were detected with avidin-DCS conjugated to FITC and biotinylated anti-avidin DCS (Vector Laboratories). For amplification of signals four layers of avidin-FITC were used.
The slides were mounted on 0.4 mg/mL DAPI (Diamidino phenylindole) and Propidium Iodide, counterstain in Vectashield Antifade buffer, and then viewed under Olympus RFL BH2 epifluorescent microscope equipped with barrier filter for FITC (O 515). The slides were photographed using Fuji 100 color film.
Detection of digoxigenin-labeled RNA probes.
The coverslips were washed for 5 minutes at room temperature with 100 mmol/L Tris-HCl pH 7.5/150 mmol/L NaCl and then for 30 minutes at room temperature with blocking buffer (100 mmol/L Tris-HCl pH7.5/150 mmol/L NaCl/saturated with blocking reagent). Then, coverslips were incubated for 30 minutes at 37 °C with anti-DIG-alkaline phosphatase (Fab fragments), and then coverslips were washed at room temperature for 10 minutes with 100 mmol/L Tris-HCl pH7.5/150 mmol/L NaCl and for 10 minutes with detection buffer (Tris-HCl pH 9.5/100 mmol/L NaCl/50 mmol/L MgCl 2 ). The coverslips were covered with detection buffer containing 0.18 mg/mL BCIP (5-bromo-4-chloro-3-indolyl phosphate), 0.34 mg/mL NBT (nitroblue tetrazolium) and 240 mg/mL levamisole and after 1 hour the color was developed. Levamisole is included in the substrate solution in order to inactivate the endogenous activity of alkaline phosphatase, since this enzyme is part of the DIG-detection system (2). The color reaction was stopped with 10 mmol/L Tris pH 8.0/1 mmol/L EDTA. The coverslips were mounted with Kaiser's solution (Merck) and were viewed under Olympus B×51 microscope.
Results and Discussion
In order to analyze SOX2 and SOX14 gene expression in carcinoma cell lines we performed RNA-RNA in situ hybridization experiments using non-radioactively labeled RNA probes. To check accurate length and integrity of RNA probes after in vitro transcription we run probes on agarose gels. One example is illustrated in Figure 1 . This experiment confirmed that newly synthesized RNA probes were intact and of correct length (Figure 1 lane 3 and Figure 1 lane 5) , therefore, could be used for in situ hybridization.
Analysis of SOX2 gene expression using biotin-and DIG-labeled probes
Sox2 are predominantly expressed in the immature, undifferentiated cells of the neural epithelium of the entire CNS (16, 17) and the switch from proliferating to differentiating cells correlates with the decrease in Sox2 expression (17) . Also, it has been shown that constitutive expression of SOX2 inhibits neuronal differentiation and results in the maintenance of progenitor characteristics (18) . It is well known that cancer cells are usually closer in their properties to immature normal cells than to more mature cell types (19) . Therefore, for SOX2 gene expression analysis we decided to use human embryonal carcinoma cell line, NT2/D1. This cell line phenotypically is an undifferentiated, pluripotent embryonic stem cells (20) , and thus is an excellent in vitro model for studying SOX2 gene expression.
We started our analysis of SOX2 mRNA in NT2/D1 cells by using biotin-labeled probes. The length and quality of in vitro transcribed SOX2 antisense and sense RNA probes were examined on agarose gel (data not shown). We continued our study by performing in situ hybridization using antisense SOX2 RNA probe, as well as appropriate controls (Figure 2) . Strong hybridization signal (bright green) is detected in cytoplasm when an antisense probe was used (Figure 2a) . However, although much weaker, signals are visible in negative controls. Precisely, in cells when the sense probe was used as a control (to rule out nonspecific binding, Figure 2b) , as well as in cells without probe (to rule out endogenous biotin, Figure 2c); background signals are also less abundant, but still present. This approach revealed the presence of SOX2 mRNA in NT2/D1 cells which correlates with results obtained by Northern blot analysis (21) .
The background signal seen in negative controls (Figure 2b and 2c) could be explained by the endogenous biotin naturally present in almost every tissue and cell (22) . It is well known for example, that liver is very rich in endogenous biotin (22) and since we wanted to include hepatocellular carcinoma cell line (HepG2) in our study we decided to continue our in situ hybridization analysis by using DIG-labeled RNA probes.
The DIG-labeling method is based on a steroid isolated from digitalis plants. In contrast to biotin which is present in almost every tissue and cell, the blossoms and the leaves of digitalis plants are the only natural source of digoxigenin, indicating that anti-DIG antibody will not bind to other biological material (23) . Firstly, we have checked newly synthesized DIGlabeled SOX2 probe for its integrity and length uniformity (data not shown) and then proceeded with in situ hybridization. The presence of the SOX2 mRNA was detected as a dark stain in cytoplasm after the hybridization to antisense RNA probe (Figure 3a) . All negative controls were processed alongside with the samples: sense probe (Figure 3b) showed minimal background; no probe ( Figure 3c ) and control without antibody (Figure 3d) showed no detectable signal within the cell. Results presented in Figure 3 also clearly show expression of SOX2 gene in NT2/D1 cells.
Analysis of SOX14 gene expression using DIG-labeled probes
It has been reported that human SOX14 gene is widely expressed and its transcripts were detected by RT-PCR in foetal brain, spinal cord and thymus (14) . No visible RT-PCR product was seen in adult liver RNA. Southern blot analysis of the same gel gave very faint signal on liver RNA indicating very low level of SOX14 gene expression in normal adult liver (14) .
However, by Northern blot analysis SOX14 transcript was detected in hepatocellular carcinoma cell line, HepG2 (14) indicating that SOX14 expression might be up regulated in this carcinoma cell line, which we used as a model in our study.
The probes used in this set of experiments were shown in Figure 1 . After the hybridization to antisense RNA probe (Figure 4a) we detected the SOX14 mRNA as a dark stain in cytoplasm. As in previous experiment, sense probe (Figure 4b) showed minimal background; no probe ( Figure 4c RNA-RNA in situ hybridization is a very reliable method, which enables visualization of hybridization to specific mRNA while areas without hybridization appear blank (or unstained). This characteristic is particularly advantageous for tissue gene expression analysis. Precisely, tissues are a heterogeneous population of cells, and gene expression results obtained by Northern or RT-PCR methods reflect the whole tissue rather than a precise cell specific gene expression. Furthermore, more tissue is necessary for Northern analysis (in order to isolate RNA) than for in situ hybridization analysis. On the other hand, the smallest amount of tissue is sufficient for a successful RT-PCR (theoretically it is possible to detect only one mRNA molecule). Nevertheless, the gene expression level could not be deduced by using this method since it involves many DNA multiplications.
Therefore, RNA-RNA in situ hybridization is a very suitable approach that would allow us to perform analysis of SOX gene expression in various normal and cancer tissues.
In conclusion, we have employed non-radioactive RNA-RNA in situ hybridization where biotin-or digoxigenin-labeled RNA probes were used to detect SOX gene expression in carcinoma cell lines. If our research confirms that SOX gene expression is modified in neoplastic transformation, based on that finding it would be possible to develop diagnostic tests that could be carried out in oncology.
